Collegium Pharmaceutical
COLL
COLL
277 hedge funds and large institutions have $1.72B invested in Collegium Pharmaceutical in 2025 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 85 increasing their positions, 108 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
21% less repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 108
Holders
277
Holding in Top 10
–
Calls
$1.04M
Puts
–
Top Buyers
| 1 | +$22.5M | |
| 2 | +$21.7M | |
| 3 | +$21.3M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$13.2M |
| 5 |
D.E. Shaw & Co
New York
|
+$11M |
Top Sellers
| 1 | -$55.6M | |
| 2 | -$21.5M | |
| 3 | -$7.93M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$6.68M |
| 5 |
Goldman Sachs
New York
|
-$6.47M |
